Overexpression of the A1 adenosine receptor in adipose tissue protects mice from obesity‐related insulin resistance
- 1 October 2001
- journal article
- research article
- Published by Wiley in Diabetes, Obesity and Metabolism
- Vol. 3 (5) , 360-366
- https://doi.org/10.1046/j.1463-1326.2001.00158.x
Abstract
Summary: In‐vitro studies have implicated the A1 adenosine receptor (A1AR) of adipocytes in inhibition of lipolysis, stimulation of lipogenesis and enhancement of the action of insulin on glucose metabolism. To determine whether any of these activities were physiologically relevant in an intact animal, A1AR was overexpressed in adipose tissue of transgenic mice. Lower plasma free fatty acid (FFA) levels were observed in the transgenic mice relative to the litter‐matched controls, supporting a significant physiological role for adipocyte A1AR in the control of lipolysis. However, no differences were observed in body weights or body composition. On a high fat diet, both the transgenic mice and the litter matched controls, male and female, became equally obese. Unlike the control mice, however, the transgenic mice did not develop insulin resistance, as demonstrated by serum glucose and insulin levels and glucose and insulin tolerance tests. These findings demonstrate that adipocyte A1AR plays an important physiological role in the control of insulin sensitivity in an intact animal and therefore should be considered to be a potential therapeutic target for the treatment of obesity‐related insulin resistance and type 2 diabetes.Keywords
This publication has 19 references indexed in Scilit:
- The PPARs: From Orphan Receptors to Drug DiscoveryJournal of Medicinal Chemistry, 2000
- A1 adenosine receptor of human and mouse adipose tissues: Cloning, expression, and characterizationBiochemical Pharmacology, 1999
- Combined effects of insulin treatment and adipose tissue-specific agouti expression on the development of obesityProceedings of the National Academy of Sciences, 1997
- Role of Fatty Acids in the Pathogenesis of Insulin Resistance and NIDDMDiabetes, 1997
- Adenosine Receptor Subtypes: Characterization and Therapeutic RegulationAnnual Review of Pharmacology and Toxicology, 1995
- Pathogenesis of NIDDM: A Balanced OverviewDiabetes Care, 1992
- A1 adenosine receptors in the human fat cell: tissue distribution and regulation of radioligand bindingEuropean Journal of Pharmacology: Molecular Pharmacology, 1991
- A fat-specific enhancer is the primary determinant of gene expression for adipocyte P2 in vivo.Proceedings of the National Academy of Sciences, 1990
- Catecholamines inhibit insulin‐stimulated glucose transport in adipocytes, in the presence of adenosine deaminaseFEBS Letters, 1983
- Facilitation by Adenosine of the Action of Insulin on the Accumulation of Adenosine 3′:5′‐Monophosphate, Lipolysis, and Glucose Oxidation in Isolated Fat CellsEuropean Journal of Biochemistry, 1974